Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.
about
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategiesEffect of expanded US recommendations for seasonal influenza vaccination: comparison of two pediatric emergency departments in the United States and CanadaHerd effect from influenza vaccination in non-healthcare settings: a systematic review of randomised controlled trials and observational studiesInfluenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildrenThe population impact of a large school-based influenza vaccination campaignThe Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.School-based influenza vaccination: parents' perspectives.Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planningEthics and public health emergencies: rationing vaccines.Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004Modelling control measures to reduce the impact of pandemic influenza among schoolchildren.School closure may be effective in reducing transmission of respiratory viruses in the community.Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease.Statewide school-located influenza vaccination program for children 5-13 years of age, Hawaii, USA.Influenza vaccines: from surveillance through production to protection.Bench-to-bedside review: vaccine protection strategies during pandemic flu outbreaks.Influenza A virus transmission: contributing factors and clinical implications.Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.Influenza vaccination coverage rate in children: reasons for a failure and how to go forward.Description of a large urban school-located 2009 pandemic H1N1 vaccination campaign, New York City 2009-2010.Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza.The burden of seasonal and pandemic influenza in infants and children.Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.The effect of universal influenza immunization on mortality and health care use.Modeling seasonal influenza outbreak in a closed college campus: impact of pre-season vaccination, in-season vaccination and holidays/breaksInfluenza vaccination rates of children in households with high-risk adults.Parental perceptions of school-based influenza immunisation in Ontario, Canada: a qualitative study.Childhood Hib vaccination and pneumonia and influenza burden in US seniorsSame influenza vaccination strategies but different outcomes across US cities?School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance.Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants.Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology AssessmentAn approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static modelsRelative timing of influenza disease by age group.Active learning to understand infectious disease models and improve policy making.The role of heterogeneity in contact timing and duration in network models of influenza spread in schools.The human side of influenza.Association of Influenza Vaccination Coverage in Younger Adults With Influenza-Related Illness in the Elderly.Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.
P2860
Q22305437-56F1FF3C-DD22-48A7-96C3-15D085D10104Q24635905-DF60A73F-4162-4D2F-8CAD-82A558460D7BQ28066385-2E72B5F1-F3FB-4822-A450-B1B64FB323F4Q28743079-E04AFDFC-2490-4931-A41B-0E67DE22E473Q28743825-AA6351F7-D278-4758-851D-F9F6969D5E21Q30205724-BE006675-2CE4-4949-B2D2-20346107B548Q30210618-32B8E9EF-BB26-4E4F-B9E9-D09013B6CC48Q30230076-DF1ADA22-6C7B-4806-A9E6-176CE7E9F076Q30357813-98FDFD88-6D9F-4008-A010-C442AB004A7BQ30360764-6FAC3207-D889-433C-A4CB-F7F2EF7F3289Q30364559-DE42B7B7-6077-4343-B357-CC6321B9C55DQ30376021-69910F2E-4BE0-45E9-B6FC-9339ACE47E33Q30379858-C1759567-D3AC-48DB-B374-2F206097D854Q30384321-69B25933-AA7F-4944-A61B-20F2ECD64AEBQ30385051-D13324B2-CC64-4097-AC0E-2DB49CAFDDC2Q30385118-6C267C3F-89CC-471E-AC6E-C07A4CFAA979Q30389582-B11FA6AA-F4A8-4F85-A311-462FB8C66E70Q30397203-262991C7-ED92-46BC-A8EF-6B2329A885B1Q30400623-F7F86E75-217F-4BF2-B244-47E6CAF043ABQ30411868-CA161A77-3C3C-4038-B3A6-6E21E6FBA426Q30412796-34AB0C13-24D7-4417-B7FB-A2BCB8730107Q30412892-8489D684-BEC7-46FE-8628-452E56BE5516Q30430303-997E5BE6-8ECC-484D-9B93-597B97F42FEAQ31166045-E2793B95-A17A-48CF-88DF-F3525C3596FDQ33380394-DE916A2A-F781-4EE4-B33D-B997A9C6823CQ33537982-0E7E2F1F-9EC5-4DBD-84CA-FE1F16BA4FA8Q33652685-BEDCF1DA-0605-4A26-83DB-052024DE237EQ33744899-5D983252-6835-4002-86DF-DF4F7C65A4A6Q34044178-F8C96792-CF0F-4873-8BFA-596514AE957AQ34137742-F6213A6F-F96B-4E20-9455-A8098A5C82E3Q34137789-D89F198F-A6FA-45D0-AEDD-5273C6961C63Q34279996-C652DD17-C8FD-40F9-84CC-E5EA8F5AC0F6Q34446848-ACD26432-81E7-4975-AA0F-82D9EBF2F2BBQ34556941-E0AE580E-71A7-4D3E-8289-5FE9FB7DCB58Q34613067-34FD9FB7-D059-4EED-B2D1-BA667BBC1A85Q35151816-E6BDAFC5-644D-492F-B53D-8311D504FB51Q35927044-B130E10F-1347-407C-89C4-DCDE94AD031BQ36055988-AD6DFE4E-D0E7-49A7-A32A-10376F9F8D71Q36187657-C14E29F3-5C2A-41E3-A8E6-32A85CCC0F13Q36294177-43498230-B141-480F-823B-1C72E8E0F2D2
P2860
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Herd immunity in adults agains ...... vaccine (CAIV-T) in children.
@en
Herd immunity in adults agains ...... e attenuated influenza vaccine
@nl
type
label
Herd immunity in adults agains ...... vaccine (CAIV-T) in children.
@en
Herd immunity in adults agains ...... e attenuated influenza vaccine
@nl
prefLabel
Herd immunity in adults agains ...... vaccine (CAIV-T) in children.
@en
Herd immunity in adults agains ...... e attenuated influenza vaccine
@nl
P2093
P1433
P1476
Herd immunity in adults agains ...... vaccine (CAIV-T) in children.
@en
P2093
Charles Fewlass
Claudia A Kozinetz
Colin Hessel
Gayla Herschler
Julie Cordova
Manjusha J Gaglani
Mark Riggs
Matt Watts
Melissa Griffith
Pedro A Piedra
P304
P356
10.1016/J.VACCINE.2004.09.025
P407
P577
2005-02-01T00:00:00Z